Literature DB >> 8110190

The inhibition of phosphoinositide synthesis and muscarinic-receptor-mediated phospholipase C activity by Li+ as secondary, selective, consequences of inositol depletion in 1321N1 cells.

I H Batty1, C P Downes.   

Abstract

Conditions are described for culture of 1321N1 cells under which cellular inositol is decreased from approximately 20 mM to < 0.5 mM but phosphoinositide concentrations are unaffected. The effects of the muscarinic-receptor agonist carbachol (1 mM) and/or LiCl (10 mM) on phosphoinositide turnover in these or in inositol-replete cells was examined after steady-state [3H]inositol labelling of phospholipid pools. In both inositol-replete and -depleted cells, carbachol stimulated similar initial (0-15 min) rates of phospholipase C (PLC) activity, in the presence of Li+. Subsequently (> 30-60 min) stimulated PLC activity and [3H]PtdIns concentrations declined dramatically only in depleted cells. In inositol-depleted cells, carbachol alone evoked increased concentrations of [3H]inositol, [3H]InsP1, [3H]InsP2, [3H]InsP3 and [3H]InsP4, which were largely sustained over 90 min, and concentrations of [3H]PtdIns, [3H]PtdInsP and [3H]PtdInsP2 were decreased only to approximately 82, 84 and 93% of control respectively. In the presence of Li+ in these cells, the stimulated rise in [3H]inositol was prevented and, although accumulation of [3H]InsP1, [3H]InsP2 and [3H]InsP3 was initially (0-30 min) potentiated, rates of accumulation of [3H]InsP1 and concentrations of [3H]polyphosphates later (> 30-60 min) declined, and concentrations of [3H]PtdIns, [3H]PtdInsP and [3H]PtdInsP2 were decreased respectively to approximately 39, 48 and 81% of control. After 60 min in the presence of both carbachol and Li+, stimulated PLC activity was decreased by approximately 70% compared with the initial rate in depleted cells. This decreased PLC activity was reflected by changes in the stimulated concentrations of [3H]Ins(1,3,4)P3 but not of [3H]Ins(1,4,5)P3, but effects of Li+ on the latter may have been obscured by the demonstrated, concomitant and equal stimulated accumulation of [3H]inositol 1:2cyclic,4,5-trisphosphate. These data suggest that receptor-mediated PLC activity is selectively impaired by Li+ as a secondary consequence of inositol monophosphatase inhibition in cells which are highly dependent on inositol re-cycling, but imply that, although Li+ attenuation of PLC activity correlates closely with parameters indicative of limiting inositol supply, it is not readily attributed to decreased PtdInsP2 availability. The potential for complex regulation of PLC and PtdIns synthase is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110190      PMCID: PMC1137866          DOI: 10.1042/bj2970529

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  Increased brain myo-inositol 1-phosphate in lithium-treated rats.

Authors:  J H Allison; M E Blisner; W H Holland; P P Hipps; W R Sherman
Journal:  Biochem Biophys Res Commun       Date:  1976-07-26       Impact factor: 3.575

2.  Reduced brain inositol in lithium-treated rats.

Authors:  J H Allison; M A Stewart
Journal:  Nat New Biol       Date:  1971-10-27

3.  Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.

Authors:  S B Masters; M T Quinn; J H Brown
Journal:  Mol Pharmacol       Date:  1985-03       Impact factor: 4.436

4.  Breakdown of polyphosphoinositides and not phosphatidylinositol accounts for muscarinic agonist-stimulated inositol phospholipid metabolism in rat parotid glands.

Authors:  C P Downes; M M Wusteman
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

5.  The interaction of lithium with thyrotropin-releasing hormone-stimulated lipid metabolism in GH3 pituitary tumour cells. Enhancement of stimulated 1,2-diacylglycerol formation.

Authors:  A H Drummond; C A Raeburn
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

6.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Authors:  L M Hallcher; W R Sherman
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

7.  Effects of lithium on angiotensin-stimulated phosphatidylinositol turnover and aldosterone production in adrenal glomerulosa cells: a possible causal relationship.

Authors:  T Balla; P Enyedi; L Hunyady; A Spät
Journal:  FEBS Lett       Date:  1984-06-11       Impact factor: 4.124

8.  Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices.

Authors:  E D Kennedy; R A Challiss; C I Ragan; S R Nahorski
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

9.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

10.  Relationships between phosphoinositide and calcium responses to muscarinic agonists in astrocytoma cells.

Authors:  S B Masters; T K Harden; J H Brown
Journal:  Mol Pharmacol       Date:  1984-09       Impact factor: 4.436

View more
  22 in total

1.  A highly dynamic ER-derived phosphatidylinositol-synthesizing organelle supplies phosphoinositides to cellular membranes.

Authors:  Yeun Ju Kim; Maria Luisa Guzman-Hernandez; Tamas Balla
Journal:  Dev Cell       Date:  2011-11-15       Impact factor: 12.270

Review 2.  Defining signal transduction by inositol phosphates.

Authors:  Stephen B Shears; Sindura B Ganapathi; Nikhil A Gokhale; Tobias M H Schenk; Huanchen Wang; Jeremy D Weaver; Angelika Zaremba; Yixing Zhou
Journal:  Subcell Biochem       Date:  2012

3.  Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.

Authors:  N R Leslie; D Bennett; A Gray; I Pass; K Hoang-Xuan; C P Downes
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

4.  Epi-inositol is biochemically active in reversing lithium effects on cytidine monophosphorylphosphatidate (CMP-PA). Short communication.

Authors:  M H Richards; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 5.  Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

Authors:  Robin S B Williams
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

6.  Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1.

Authors:  Ian N Fleming; Ian H Batty; Alan R Prescott; Alex Gray; Gursant S Kular; Hazel Stewart; C Peter Downes
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

7.  Membrane lipid composition plays a central role in the maintenance of epithelial cell adhesion to the extracellular matrix.

Authors:  María Gabriela Márquez; Francisco Leocata Nieto; María C Fernández-Tome; Nicolás Octavio Favale; Norma Sterin-Speziale
Journal:  Lipids       Date:  2008-02-21       Impact factor: 1.880

8.  Fibrinogen - a possible extracellular target for inositol phosphates.

Authors:  Thomas Grint; Andrew M Riley; Stephen J Mills; Barry V L Potter; Stephen T Safrany
Journal:  Messenger (Los Angel)       Date:  2012-12-01

9.  Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.

Authors:  Ian H Batty; Ian N Fleming; C Peter Downes
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

10.  Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.

Authors:  Xiuwen Tang; Lijun Wang; Christopher G Proud; C Peter Downes
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.